ClinConnect ClinConnect Logo
Search / Trial NCT06385860

Prediction Model for Early Biliary Stasis After Bariatric Surgery

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Apr 23, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on developing a tool to help predict the risk of early biliary stasis after bariatric surgery, which is a type of weight-loss surgery. Biliary stasis occurs when bile, a digestive fluid, doesn't flow properly, and it can lead to complications. The researchers aim to create a model that will help doctors identify patients who may be at higher risk for this condition after surgery.

To participate in the trial, you would need to be between the ages of 18 and 65 and have a body mass index (BMI) of 32.5 or higher, along with conditions related to obesity, or a BMI over 35 without other medical issues. Participants will need to provide complete medical information before and after the surgery. However, those who have had other types of bariatric surgery or who cannot safely undergo the procedure are not eligible. If you join this study, you’ll be contributing to important research that may help improve outcomes for future patients undergoing bariatric surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. BMI ≥32.5 kg/m2 with one or more obesity-related comorbidities.
  • 2. BMI \>35 kg/m2 without coexisting medical problems
  • 3. complete preoperative and follow-up data.
  • Exclusion Criteria:
  • 1. other bariatric procedures.
  • 2. contraindications for bariatric surgery.

About China Japan Friendship Hospital

China-Japan Friendship Hospital is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. Established as a collaborative effort between China and Japan, the hospital integrates cutting-edge technology with traditional medical practices, fostering a multidisciplinary approach to patient care and clinical studies. The institution is committed to enhancing therapeutic outcomes and improving patient safety while adhering to rigorous ethical standards. With a diverse team of experienced healthcare professionals and researchers, China-Japan Friendship Hospital plays a pivotal role in addressing global health challenges and contributing to medical knowledge through its extensive clinical trial programs.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported